These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 30293987)

  • 1. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease.
    Alankarage D; Ip E; Szot JO; Munro J; Blue GM; Harrison K; Cuny H; Enriquez A; Troup M; Humphreys DT; Wilson M; Harvey RP; Sholler GF; Graham RM; Ho JWK; Kirk EP; Pachter N; Chapman G; Winlaw DS; Giannoulatou E; Dunwoodie SL
    Genet Med; 2019 May; 21(5):1111-1120. PubMed ID: 30293987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.
    Szot JO; Cuny H; Blue GM; Humphreys DT; Ip E; Harrison K; Sholler GF; Giannoulatou E; Leo P; Duncan EL; Sparrow DB; Ho JWK; Graham RM; Pachter N; Chapman G; Winlaw DS; Dunwoodie SL
    Circ Genom Precis Med; 2018 Mar; 11(3):e001978. PubMed ID: 29555671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
    Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
    Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
    Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
    Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From genes to therapy: A comprehensive exploration of congenital heart disease through the lens of genetics and emerging technologies.
    Nawaz K; Alifah N; Hussain T; Hameed H; Ali H; Hamayun S; Mir A; Wahab A; Naeem M; Zakria M; Pakki E; Hasan N
    Curr Probl Cardiol; 2024 Sep; 49(9):102726. PubMed ID: 38944223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital.
    Hauser NS; Solomon BD; Vilboux T; Khromykh A; Baveja R; Bodian DL
    Mol Genet Genomic Med; 2018 Mar; 6(2):200-212. PubMed ID: 29368431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Pass Genome Sequencing: Validation and Diagnostic Utility from 409 Clinical Cases of Low-Pass Genome Sequencing for the Detection of Copy Number Variants to Replace Constitutional Microarray.
    Chaubey A; Shenoy S; Mathur A; Ma Z; Valencia CA; Reddy Nallamilli BR; Szekeres E; Stansberry L; Liu R; Hegde MR
    J Mol Diagn; 2020 Jun; 22(6):823-840. PubMed ID: 32344035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
    Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
    Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.
    Minoche AE; Horvat C; Johnson R; Gayevskiy V; Morton SU; Drew AP; Woo K; Statham AL; Lundie B; Bagnall RD; Ingles J; Semsarian C; Seidman JG; Seidman CE; Dinger ME; Cowley MJ; Fatkin D
    Genet Med; 2019 Mar; 21(3):650-662. PubMed ID: 29961767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
    LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
    Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
    Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
    J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Analysis in the Age of Human Genome Sequencing.
    Lappalainen T; Scott AJ; Brandt M; Hall IM
    Cell; 2019 Mar; 177(1):70-84. PubMed ID: 30901550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
    Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
    Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of targeted next-generation sequencing in fetuses with congenital heart defect.
    Hu P; Qiao F; Wang Y; Meng L; Ji X; Luo C; Xu T; Zhou R; Zhang J; Yu B; Wang L; Wang T; Pan Q; Ma D; Liang D; Xu Z
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):205-211. PubMed ID: 29536580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Interpretation of Sequence Variants.
    Zhang J; Yao Y; He H; Shen J
    Curr Protoc Hum Genet; 2020 Jun; 106(1):e98. PubMed ID: 32176464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The updates of the ACMG variant interpretation guidelines affect the pathogenicity determination of
    Wu KL; Li J; Wang HY; Wang QJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 59(5):455-463. PubMed ID: 38811176
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
    Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
    Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic sequencing identifies secondary findings in a cohort of parent study participants.
    Thompson ML; Finnila CR; Bowling KM; Brothers KB; Neu MB; Amaral MD; Hiatt SM; East KM; Gray DE; Lawlor JMJ; Kelley WV; Lose EJ; Rich CA; Simmons S; Levy SE; Myers RM; Barsh GS; Bebin EM; Cooper GM
    Genet Med; 2018 Dec; 20(12):1635-1643. PubMed ID: 29790872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.
    El Malti R; Liu H; Doray B; Thauvin C; Maltret A; Dauphin C; Gonçalves-Rocha M; Teboul M; Blanchet P; Roume J; Gronier C; Ducreux C; Veyrier M; Marçon F; Acar P; Lusson JR; Levy M; Beyler C; Vigneron J; Cordier-Alex MP; Heitz F; Sanlaville D; Bonnet D; Bouvagnet P
    Eur J Hum Genet; 2016 Feb; 24(2):228-36. PubMed ID: 26014430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validated heart-specific model for splice-disrupting variants in childhood heart disease.
    Lesurf R; Breckpot J; Bouwmeester J; Hanafi N; Jain A; Liang Y; Papaz T; Lougheed J; Mondal T; Alsalehi M; Altamirano-Diaz L; Oechslin E; Audain E; Dombrowsky G; Postma AV; Woudstra OI; Bouma BJ; Hitz MP; Bezzina CR; Blue GM; Winlaw DS; Mital S
    Genome Med; 2024 Oct; 16(1):119. PubMed ID: 39402625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.